Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
641
NCT03637556
Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 20, 2019
Completion: Aug 16, 2021
NCT04291664
PK and Dose Escalation and Expansion Study of DST-2970
Phase: Phase 1
Start: Jan 31, 2020
Completion: Jan 27, 2023
NCT06920108
TRACE4BUS for BI-RADS Classification
Phase: N/A
Start: Apr 30, 2025
Completion: Oct 31, 2026